Product Description
Alfadex also known as alpha-cyclodextrin, is used as an inactive ingredient in order to improve the water solubility of the different drugs, e.g. edex: is a sterile, pyrogen-free powder containing alprostadil in an alfadex inclusion complex. (Sourced from: https://drugs.ncats.io/drug/Z1LH97KTRM)
Mechanisms of Action: EP1 Analogue
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Austria | Colombia | Japan | Korea | Pakistan | Taiwan | Turkey
Approved Indications: None
Known Adverse Events: None
Company: Sino Biopharmaceutical
Company Location: NEW YORK NY 10005
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 3: Overweight|Prediabetes|Obesity
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| ACTRN12614001302640 | P3 |
Completed |
Overweight|Prediabetes|Obesity |
2018-03-22 |
|
| FMAT | N/A |
Completed |
Healthy Volunteers |
2017-06-05 |
|
| FMAT | N/A |
Completed |
Healthy Volunteers |
2017-06-01 |
|
| FAT ABSORBER | N/A |
Withdrawn |
Obesity |
2013-10-01 |